Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-028851

Adamas Pharmaceuticals Inc · ADMS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Gregory T Went
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 20, 2015M100$1.875A10,108D
Common StockF1Mar 20, 2015S100$18.00D10,008D
Common StockF1Mar 20, 2015S200$18.00D405,980IGregory T Went & Marjorie S Went ttees Went Family Living Trust dtd 03/24/11
Common Stockholding———6,666IGregory T Went Cust - Bridget Went Under CA Uniform Transfers to Minors Act
Common Stockholding———6,666IGregory T Went Cust - Cora Went Under CA Uniform Transfers to Minors Act
Common Stockholding———80,000IGregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Bridget Elise Went
Common Stockholding———80,000IGregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Cora Margaret Went

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$1.875Mar 20, 2015M100D—Sep 12, 2016Common Stock100231,080D

Explanation of responses